Your browser doesn't support javascript.
Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable "Omicron ghosts" and insights from CAR-T cell therapy pointing toward better clinical outcomes.
Seghatchian, Jerard.
  • Seghatchian J; International Consultancy in Innovative Manufacturing and Quality/Safety of Blood-Derived Bioproducts, London, England, UK. Electronic address: jseghatchian@btopenworld.com.
Transfus Apher Sci ; 61(4): 103490, 2022 08.
Article in English | MEDLINE | ID: covidwho-2016142

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Chimeric Antigen / COVID-19 / Neoplasms Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid / Variants Limits: Humans Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Chimeric Antigen / COVID-19 / Neoplasms Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid / Variants Limits: Humans Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2022 Document Type: Article